4,506 results match your criteria Archivum Immunologiae Et Therapiae Experimentalis[Journal]


Transcriptome Studies in Lupus Nephritis.

Arch Immunol Ther Exp (Warsz) 2022 Apr 25;70(1):15. Epub 2022 Apr 25.

GENYO. Center for Genomics and Oncological Research. Pfizer / University of Granada / Andalusian Regional Government, Av de la Ilustración 114, 18016, Granada, Spain.

The present review is aimed at describing the main works that have used gene expression to analyze tissue kidney samples of lupus nephritis patients. Most studies used the gene expression arrays, which enormously advanced our knowledge on the possible mechanisms behind lupus nephritis. However, using bulk gene expression platforms, either as arrays, or as sequencing of RNA is not enough to go into detail of the cells and their molecular patterns and single cell mechanisms of disease. Read More

View Article and Full-Text PDF

Hydroxychloroquine Therapy and Serum Immunoglobulin Levels in Women with IgG Subclass Deficiency and Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis: A Retrospective Study.

Arch Immunol Ther Exp (Warsz) 2022 Apr 11;70(1):14. Epub 2022 Apr 11.

Department of Medicine, Brookwood Medical Center, Birmingham, AL, USA.

Hydroxychloroquine (HCQ) therapy decreased immunoglobulin (Ig) levels in patients with Sjögren syndrome (SS) and rheumatoid arthritis (RA) in previous studies. We found no report of Ig levels of women with IgG subclass deficiency (IgGSD) and systemic lupus erythematosus (SLE), SS, or RA treated with HCQ. We retrospectively evaluated IgG, IgG subclass, IgA, and IgM levels and other characteristics of women at IgGSD diagnosis who did and did not take HCQ for SLE, SS, or RA. Read More

View Article and Full-Text PDF

Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic.

Arch Immunol Ther Exp (Warsz) 2022 Mar 24;70(1):13. Epub 2022 Mar 24.

Department of Gynecology and Oncological Gynecology, Military Medical Institute, Warsaw, Poland.

Increased androgen level, hyperinsulinemia, diabetes, impaired fibrinolysis, obesity, hypertension, chronic inflammation, abnormal immune response to infections and hyperhomocysteinemia are the most common abnormalities related to polycystic ovary syndrome (PCOS) women and are the factors predisposing to the severe course of COVID-19. The SARS-Cov-2 infection during pregnancy is associated with an increased risk of complications (spontaneous abortion), similar to those in PCOS. The treatment of PCOS pregnant women with a history of fertility failures raises many doubts, especially during the COVID pandemic. Read More

View Article and Full-Text PDF

Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients.

Arch Immunol Ther Exp (Warsz) 2022 Mar 18;70(1):12. Epub 2022 Mar 18.

Rheumatology and Immune-Mediated Diseases Research Group (IRIDIS), Galicia Sur Health Research Institute (IISGS), SERGAS-UVIGO, Vigo, Spain.

In rheumatoid arthritis (RA), the identification of biomarkers to adjust treatment intensity and to correctly diagnose the disease in early stages still constitutes a challenge and, as such, novel biomarkers are needed. We proposed that autoantibodies (aAbs) against CD26 (DPP4) might have both etiological importance and clinical value. Here, we perform a prospective study of the potential diagnostic power of Anti-CD26 aAbs through their quantification in plasmas from 106 treatment-naïve early and undifferentiated AR. Read More

View Article and Full-Text PDF

New Treatment Options in Lupus Nephritis.

Arch Immunol Ther Exp (Warsz) 2022 Mar 17;70(1):11. Epub 2022 Mar 17.

Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Mounier, 53, 1200, Bruxelles, Belgium.

The aim of this study is to report major recent progresses in the treatment of lupus nephritis (LN). Results of controlled randomized trials are discussed in view of the unmet needs in the field. Current treatments of LN are not satisfactory, with a disappointing proportion of 20-30% of patients achieving complete renal response within 6-12 months, and 5-20% developing end-stage kidney disease within ten years. Read More

View Article and Full-Text PDF

CD5L Secreted by Macrophage on Atherosclerosis Progression Based on Lipid Metabolism Induced Inflammatory Damage.

Arch Immunol Ther Exp (Warsz) 2022 Mar 6;70(1):10. Epub 2022 Mar 6.

Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.

To explore the molecular mechanism of exosomal protein CD5L secreted by macrophage to promote the progression of atherosclerosis. Twenty cases of patients with atherosclerosis (AS) and 20 cases of healthy subjects were collected. Morphological properties of exosomes were identified by transmission electron microscopy, and the marker proteins CD63 and CD81 of exosomes were measured by Western blot. Read More

View Article and Full-Text PDF

Recombinant Human Lactoferrin Reduces Inflammation and Increases Fluoroquinolone Penetration to Primary Granulomas During Mycobacterial Infection of C57Bl/6 Mice.

Arch Immunol Ther Exp (Warsz) 2022 Feb 28;70(1). Epub 2022 Feb 28.

Department of Pathology and Laboratory Medicine, MSB 2.214, UTHealth McGovern Medical School, 6431 Fannin, Houston, TX, 77030, USA.

Infection with Mycobacterium tuberculosis (Mtb) results in the primary formation of a densely packed inflammatory foci that limits entry of therapeutic agents into pulmonary sites where organisms reside. No current therapeutic regimens exist that modulate host immune responses to permit increased drug penetration to regions of pathological damage during tuberculosis disease. Lactoferrin is a natural iron-binding protein previously demonstrated to modulate inflammation and granuloma cohesiveness, while maintaining control of pathogenic burden. Read More

View Article and Full-Text PDF
February 2022

Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?

Arch Immunol Ther Exp (Warsz) 2022 Feb 11;70(1). Epub 2022 Feb 11.

Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.

Kidney involvement, termed lupus nephritis (LN), develops in 35-60% of patients with systemic lupus erythematosus, often early during the disease course. When not treated promptly and efficiently, LN may lead to rapid and severe loss of kidney function, being the reason why it is considered one of the most severe lupus manifestations. Despite improved pharmacotherapy, 5-20% of LN patients develop end-stage kidney disease within ten years from the LN diagnosis. Read More

View Article and Full-Text PDF
February 2022

The Role of Gut Microbiota in Gastrointestinal Tract Cancers.

Arch Immunol Ther Exp (Warsz) 2022 Feb 3;70(1). Epub 2022 Feb 3.

Department of Immunopathology, Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.

Disturbances in gastrointestinal (GI) microbiota could play a significant role in the development of GI cancers, but the underlying mechanisms remain largely unclear. While some bacteria seem to facilitate carcinogenesis, others appear to be protective. So far only one bacterium (Helicobacter pylori) has been classified by the International Agency for Cancer Research as carcinogenic in humans but many other are the subject of intense research. Read More

View Article and Full-Text PDF
February 2022

Effects of Local Nasal Immunotherapy with FIP-fve Peptide and Denatured Tyrophagus putrescentiae for Storage Mite-Induced Airway Inflammation.

Arch Immunol Ther Exp (Warsz) 2022 Jan 31;70(1). Epub 2022 Jan 31.

Department of Medicine, MacKay Medical College, No. 46, Sec.3, Jhong-Jheng Rd. San-Jhih, New Taipei City, 24245, Taiwan.

Allergic diseases are affecting public health and have increased over the last decade. Sensitization to mite allergens is a considerable trigger for allergy development. Storage mite-Tyrophagus putrescentiae shows great significance of allergenic potential and clinical relevance. Read More

View Article and Full-Text PDF
January 2022

The Role of Immunoproteasomes in Tumor-Immune Cell Interactions in Melanoma and Colon Cancer.

Arch Immunol Ther Exp (Warsz) 2022 Jan 22;70(1). Epub 2022 Jan 22.

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany.

The participation of proteasomes in vital cellular and metabolic processes that are involved in tumor growth has made this protease complex an attractive target for cancer treatment. In contrast to ubiquitously available constitutive proteasome, the increased enzymatic activity of immunoproteasome is associated with tumor-infiltrating immune cells, such as antigen-presenting cells and T lymphocytes. In various tumors, an effective anti-tumor immunity is provided through generation of tumor-associated antigens by proteasomes, contributing crucially to cancer eradication by T lymphocytes. Read More

View Article and Full-Text PDF
January 2022

Rho Kinases in Embryonic Development and Stem Cell Research.

Arch Immunol Ther Exp (Warsz) 2022 Jan 19;70(1). Epub 2022 Jan 19.

Herman B Wells Center for Pediatric Research, Department of Pediatrics, School of Medicine, Indiana University, 1044 West Walnut Street, R4-370, Indianapolis, IN, 46202-5225, USA.

The Rho-associated coiled-coil containing kinases (ROCKs or Rho kinases) belong to the AGC (PKA/PKG/PKC) family of serine/threonine kinases and are major downstream effectors of small GTPase RhoA, a key regulator of actin-cytoskeleton reorganization. The ROCK family contains two members, ROCK1 and ROCK2, which share 65% overall identity and 92% identity in kinase domain. ROCK1 and ROCK2 were assumed to be functionally redundant, based largely on their major common activators, their high degree kinase domain homology, and study results from overexpression with kinase constructs or chemical inhibitors. Read More

View Article and Full-Text PDF
January 2022

Peroxiredoxins as Markers of Oxidative Stress in IgA Nephropathy, Membranous Nephropathy and Lupus Nephritis.

Arch Immunol Ther Exp (Warsz) 2021 Dec 16;70(1). Epub 2021 Dec 16.

Department of Immunology, Transplantology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.

IgA nephropathy (IgAN), membranous nephropathy (MN), and lupus nephritis (LN) represent important causes of chronic kidney disease. They belong to the immune-mediated glomerulonephritis (GNs), and have distinct pathogenesis, distinct clinical courses, and variable responses to treatment. Therefore, specific diagnostic procedures are necessary for more effective patient management. Read More

View Article and Full-Text PDF
December 2021

Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies.

Arch Immunol Ther Exp (Warsz) 2021 Dec 12;70(1). Epub 2021 Dec 12.

Leucid Bio Ltd, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK.

Technologies required to generate induced pluripotent stem cells (iPSC) were first described 15 years ago, providing a strong impetus to the field of regenerative medicine. In parallel, immunotherapy has finally emerged as a clinically meaningful modality of cancer therapy. In particular, impressive efficacy has been achieved in patients with selected haematological malignancies using ex vivo expanded autologous T cells engineered to express chimeric antigen receptors (CARs). Read More

View Article and Full-Text PDF
December 2021

A Novel Human Recombinant Lactoferrin Inhibits Lung Adenocarcinoma Cell Growth and Migration with No Cytotoxic Effect on Normal Human Epithelial Cells.

Arch Immunol Ther Exp (Warsz) 2021 Nov 8;69(1):33. Epub 2021 Nov 8.

PharmaReview Corporation, Houston, TX, USA.

Lung cancer remains the leading cause of cancer death worldwide. Despite the recent advances in cancer treatment, only a subset of patients responds to targeted and immune therapies, and many patients developing resistance after an initial response. Lactoferrin (Lf) is a natural glycoprotein with immunomodulatory and anticancer activities. Read More

View Article and Full-Text PDF
November 2021

Immunology and Donor-Specific Antibodies in Corneal Transplantation.

Arch Immunol Ther Exp (Warsz) 2021 Nov 6;69(1):32. Epub 2021 Nov 6.

Department of Immunology, Transplantology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.

The first human corneal transplantation was performed in 1905 by Eduard Zirm in the Olomouc Eye Clinic, now Czech Republic. However, despite great advancements in microsurgical eye procedures, penetrating keratoplasty in high-risk patients (e.g. Read More

View Article and Full-Text PDF
November 2021

Differential Leukocyte MicroRNA Responses Following Pan T Cell, Allorecognition and Allosecretome-Based Therapeutic Activation.

Arch Immunol Ther Exp (Warsz) 2021 Oct 22;69(1):30. Epub 2021 Oct 22.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.

Effective immunomodulation of T-cell responses is critical in treating both autoimmune diseases and cancer. Our previous studies have demonstrated that secretomes derived from control or methoxypolyethylene glycol mixed lymphocyte alloactivation assays exerted potent immunomodulatory activity that was mediated by microRNAs (miRNA). The immunomodulatory effects of biomanufactured miRNA-based allo-secretome therapeutics (SYN, TA1, IA1 and IA2) were compared to Pan T-cell activators (PHA and anti-CD3/CD28) and lymphocyte alloactivation. Read More

View Article and Full-Text PDF
October 2021

Molecular Genetics Diversity of Primary Hemophagocytic Lymphohistiocytosis among Polish Pediatric Patients.

Arch Immunol Ther Exp (Warsz) 2021 Oct 22;69(1):31. Epub 2021 Oct 22.

Department of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Żwirki i Wigury 63A, 02-091, Warsaw, Poland.

Hemophagocytic lymphohistiocytosis (HLH) is a clinical syndrome of life-threatening inflammation caused by an excessive, prolonged and ineffective immune response. An increasing number of HLH cases is recognized in Poland, but the genetic causes of familial HLH (FHL) have not been reported. We investigated the molecular genetics and associated outcomes of pediatric patients who met HLH criteria. Read More

View Article and Full-Text PDF
October 2021

The Role of Non-essential Amino Acids in T Cell Function and Anti-tumour Immunity.

Arch Immunol Ther Exp (Warsz) 2021 Oct 12;69(1):29. Epub 2021 Oct 12.

Leeds Institute of Medical Research at St. James's, University of Leeds, St. James University Hospital, Leeds, LS9 7TF, UK.

T cell activation, differentiation and proliferation is dependent upon and intrinsically linked to a capacity to modulate and adapt cellular metabolism. Antigen-induced activation stimulates a transcriptional programme that results in metabolic reprogramming, enabling T cells to fuel anabolic metabolic pathways and provide the nutrients to sustain proliferation and effector responses. Amino acids are key nutrients for T cells and have essential roles as building blocks for protein synthesis as well as in numerous metabolic pathways. Read More

View Article and Full-Text PDF
October 2021

The Positive Impact of Donor Bone Marrow Cells Transplantation into Immunoprivileged Compartments on the Survival of Vascularized Skin Allografts.

Arch Immunol Ther Exp (Warsz) 2021 Oct 11;69(1):28. Epub 2021 Oct 11.

Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Using the vascularized skin allograft (VSA) model, we compared the tolerogenic effects of different allogeneic bone marrow transplantation (BMT) delivery routes into immunoprivileged compartments under a 7-day protocol immunosuppressive therapy. Twenty-eight fully MHC mismatched VSA transplants were performed between ACI (RT1) donors and Lewis (RT1) recipients in four groups of seven animals each, under a 7-day protocol of alfa/beta TCRmAb/CsA (alpha/beta-TCR monoclonal antibodies/Cyclosporine A therapy). Donor bone marrow cells (BMC) (100 × 106 cells) were injected into three different immunoprivileged compartments: Group 1: Control, without cellular supportive therapy, Group 2: Intracapsular BMT, Group 3: Intragonadal BMT, Group 4: Intrathecal BMT. Read More

View Article and Full-Text PDF
October 2021

Cyclosporine A, in Contrast to Rapamycin, Affects the Ability of Dendritic Cells to Induce Immune Tolerance Mechanisms.

Arch Immunol Ther Exp (Warsz) 2021 Oct 10;69(1):27. Epub 2021 Oct 10.

Department of Immunology, Institute of Functional Biology and Ecology, Faculty of Biology, University of Warsaw, Warsaw, Poland.

Following organ transplantation, it is essential that immune tolerance is induced in the graft recipient to reduce the risk of rejection and avoid complications associated with the long-term use of immunosuppressive drugs. Immature dendritic cells (DCs) are considered to promote transplant tolerance and may minimize the risk of graft rejection. The aim of the study was to evaluate the effects of immunosuppressive agents: rapamycin (Rapa) and cyclosporine A (CsA) on generation of human tolerogenic DCs (tolDCs) and also to evaluate the ability of these cells to induce mechanisms of immune tolerance. Read More

View Article and Full-Text PDF
October 2021

Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition.

Arch Immunol Ther Exp (Warsz) 2021 Sep 18;69(1):26. Epub 2021 Sep 18.

Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Adjuvant chemotherapy with 5-fluorouracil (5-FU) does not improve survival of patients suffering from a form of colorectal cancer (CRC) characterized by high level of microsatellite instability (MSI-H). Given the importance of autophagy and multi-drug-resistant (MDR) proteins in chemotherapy resistance, as well as the role of casein kinase 1-alpha (CK1α) in the regulation of autophagy, we tested the combined effect of 5-FU and CK1α inhibitor (D4476) on HCT116 cells as a model of MSI-H colorectal cancer. To achieve this goal, the gene expression of Beclin1 and MDR genes, ABCG2 and ABCC3 were analyzed using quantitative real-time polymerase chain reaction. Read More

View Article and Full-Text PDF
September 2021

Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic?

Arch Immunol Ther Exp (Warsz) 2021 Sep 16;69(1):25. Epub 2021 Sep 16.

Biomedical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Col. Centro Zacatecas, Interior of Alameda #45, Zacatecas, Mexico.

The term host defense peptides arose at the beginning to refer to those peptides that are part of the host's immunity. Because of their broad antimicrobial capacity and immunomodulatory activity, nowadays, they emerge as a hope to combat resistant multi-drug microorganisms and emerging viruses, such as the case of coronaviruses. Since the beginning of this century, coronaviruses have been part of different outbreaks and a pandemic, and they will be surely part of the next pandemics, this review analyses whether these peptides and their derivatives are ready to be part of the treatment of the next coronavirus pandemic. Read More

View Article and Full-Text PDF
September 2021

Chronic Prostatitis and Pelvic Pain Syndrome: Another Autoimmune Disease?

Arch Immunol Ther Exp (Warsz) 2021 Sep 14;69(1):24. Epub 2021 Sep 14.

Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People's Republic of China.

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), characterized by chronic pain in the perineum or lower abdomen regions, is a frequent disorder in men. Previous studies demonstrated that the immune mediators, including interleukin (IL)-1β, IL-6, interferon-γ, tumor necrosis factor-α, and immunoglobulins, are elevated in the expressed prostate secretions and seminal fluid of CP/CPPS men. The memory T, T helper 1 (Th1), Th17, and Th22 cells increase in the peripheral blood of CP/CPPS men. Read More

View Article and Full-Text PDF
September 2021

Should Nano-Particles be Weighed or Counted? Technical Considerations to In Vitro Testing Originated from Corpuscular Nature of Nano-Particles.

Authors:
Wojciech Kałas

Arch Immunol Ther Exp (Warsz) 2021 Aug 3;69(1):23. Epub 2021 Aug 3.

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wrocław, Poland.

The abundance of nanoparticles introduced to household products created the great expectations towards the application of nanotechnology in biology and medicine. That calls for cost-effective preliminary assessment of its cytotoxicity and biological activity. There are many attempts for creating proper guidance and standards for performing studies regarding nanoparticles. Read More

View Article and Full-Text PDF

Lower BAFF Levels in Myasthenic Patients Treated with Glucocorticoids.

Arch Immunol Ther Exp (Warsz) 2021 Aug 2;69(1):22. Epub 2021 Aug 2.

Department of Neurology, Medical University of Warsaw, Banacha 1a, 02-097, Warsaw, Poland.

B-cell activating factor (BAFF), a member of tumor necrosis factor family, activates B cells, promotes their survival and proliferation. BAFF is considered to have an influence on development of autoimmune diseases including myasthenia gravis (MG). We aimed to evaluate BAFF serum levels in MG patients, their potential connection with therapy and course of MG. Read More

View Article and Full-Text PDF

Journal Impact Factor and Self-Citations.

Arch Immunol Ther Exp (Warsz) 2021 08 2;69(1):21. Epub 2021 Aug 2.

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wrocław, Poland.

View Article and Full-Text PDF

Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression.

Arch Immunol Ther Exp (Warsz) 2021 Jul 29;69(1):20. Epub 2021 Jul 29.

Regenerative Medicine Cluster, Advanced Medical and Dental Institute, Universit Sains Malaysia, Bertam, 13200, Kepala Batas, Pulau Pinang, Malaysia.

Sole nanomaterials or nanomaterials bound to specific biomolecules have been proposed to regulate the immune system. These materials have now emerged as new tools for eliciting immune-based therapies to treat various cancers. Graphene, graphene oxide (GO) and reduced GO (rGO) are the latest nanomaterials among other carbon nanotubes that have attracted wide interest among medical industry players due to their extraordinary properties, inert-state, non-toxic and stable dispersion in a various solvent. Read More

View Article and Full-Text PDF

Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus.

Arch Immunol Ther Exp (Warsz) 2021 Jul 28;69(1):19. Epub 2021 Jul 28.

Laboratory of Experimental Immunology, Stefan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Street, Block 26, 1113, Sofia, Bulgaria.

Systemic lupus erythematosus (SLE) is a severe autoimmune disease characterized by dysfunction of immune regulation, overproduction of inflammatory cytokines and attack on normal tissues by self-reactive cells and antibodies. The main role in the pathogenesis plays the autoreactive tandem of B-T cells, responsible for lupus progression and acceleration. Both activated B and T cells express a phospholipid binding protein Annexin A1 and abnormal levels of the protein were found in murine and human autoimmune syndromes, potentiating its role as a therapeutic target. Read More

View Article and Full-Text PDF

Changes in γδT Cells in Peripheral Blood of Patients with Ulcerative Colitis Exacerbations.

Arch Immunol Ther Exp (Warsz) 2021 Jul 21;69(1):18. Epub 2021 Jul 21.

Department of Medical Biology, Jagiellonian University Medical College, Kraków, Poland.

The role of γδT cells in ulcerative colitis (UC) is well confirmed in experimental animals and demonstrated in many clinical observations. Recent investigations have indicated that UC is associated with several forms of immune imbalance, such as an imbalance between effector T cells and regulatory T cells. However, little is known about the cellular aspect of clinical colitis exacerbations. Read More

View Article and Full-Text PDF